Hosted by the Medical Association, the *"Innovative Exchange Academic Conference Series & Symposium on Dyslipidemia, Hyperglycemia, and Hypertension from a Population-Wide Perspective: Management and Challenges of Comorbidities (7th Edition)"* was successfully held online. The conference brought together renowned experts, scholars, and clinicians from fields such as cardiology, endocrinology, and general medicine to engage in in-depth discussions on the epidemiological characteristics, comprehensive management strategies, and cutting-edge advancements in the comorbidity of the "three highs" (hypertension, hyperglycemia, and hyperlipidemia). It served as a vital platform for fostering multidisciplinary collaboration and innovation in clinical practice.
The convening of this symposium holds significant meaning for the field of comorbidity management of dyslipidemia, hyperglycemia, and hypertension:
Promoting Multidisciplinary Integration – By gathering expertise from cardiology, endocrinology, general medicine, and other fields, it breaks down disciplinary barriers and advances the optimization of comprehensive management strategies for the "three highs" comorbidities.
Addressing Population-Wide Health Needs – Examining the characteristics of comorbidities from the perspectives of different age groups, including children, young and middle-aged adults, and the elderly, provides a scientific basis for precise prevention and control.
Facilitating Innovation in Clinical Practice – Through guideline interpretation, case studies, and technical discussions, it enhances the diagnostic and treatment capabilities of primary healthcare institutions in managing complex comorbidities.
Supporting the Healthy China Initiative – Contributing academic insights to the early intervention of chronic disease management and the improvement of a tiered healthcare system, the conference outcomes will be translated into clinical and public health practices, benefiting a broader patient population.
